Input 2021.03.09 15:26 | Revision 2021.03.09 15:35
The Ministry of Food and Drug Safety explained that it will implement these measures, saying it was confirmed that some drugs were manufactured differently from the licensed contents at the Binex Busan production facility. The six products discontinued on sale the previous day were Amorin Tablet, Selectin Capsule, Daxpen Tablet, Ropeshin Tablet, Selectin Capsule, and Cadillac Tablet. The 32 items added on this day reported that the proportion of production performance was not high.
An official from the Ministry of Food and Drug Safety said, “We plan to quickly complete the field investigation and necessary measures for Binex.”
Binex said, “If the KFDA’s announcement is true, we will have to discuss it with the companies.”
Binex recently formed a consortium with eight other companies and organizations in Korea to consignment production of’Sputnik V’, a new coronavirus infection (Corona 19) vaccine in Russia. An official at Binex said, “The Russian vaccine production facility is located in Songdo, Incheon, and this has nothing to do with this measure.”